HLA-G and neoplasm: At this point, HLA-G gene expression can act as a checkpoint and as a critical marker of immune tolerance in cancer-cell immune evasion, disease progression and prognosis, given that the heterogeneity of their expression in immune-suppressive microenvironments and the isoform profiles vary among tumor type and patients [3] (Figure 2).